San Diego-centered Viking Therapeutics marked alone as a serious competitor in the weight loss drug marketplace in February following revealing promising info from the mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when supplied as a weekly injection As well as in March the company unv